Compile Data Set for Download or QSAR
maximum 50k data
Found 272 Enz. Inhib. hit(s) with all data for entry = 9972
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287650(US10085984, Example 28 | US11040034, Ex. No. 28)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287651(US10085984, Example 29 | US11040034, Ex. No. 29)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287652(US10085984, Example 30 | US11040034, Ex. No. 30)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287653(US10085984, Example 31 | US11040034, Ex. No. 31)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287654(US10085984, Example 32 | US11040034, Ex. No. 32)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287655(US10085984, Example 33 | US11040034, Ex. No. 33)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287656(US10085984, Example 34 | US11040034, Ex. No. 34)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287657(US10085984, Example 35 | US11040034, Ex. No. 35)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287658(US10085984, Example 36 | US11040034, Ex. No. 36)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287659(US10085984, Example 37 | US11040034, Ex. No. 37)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287660(US10085984, Example 38 | US11040034, Ex. No. 38)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504360(US11040034, Ex. No. 39)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B1, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504360(US11040034, Ex. No. 39)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287662(US10085984, Example 40 | US11040034, Ex. No. 40)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287663(US10085984, Example 41 | US11040034, Ex. No. 41)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287664(US10085984, Example 42 | US11040034, Ex. No. 42)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287665(US10085984, Example 43 | US11040034, Ex. No. 43)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287666(US10085984, Example 44 | US11040034, Ex. No. 44)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287667(US10085984, Example 45 | US11040034, Ex. No. 45)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287668(US10085984, Example 46 | US11040034, Ex. No. 46)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287669(US10085984, Example 47 | US11040034, Ex. No. 47)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287671(US10085984, Example 49 | US11040034, Ex. No. 49)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287673(US10085984, Example 51 | US11040034, Ex. No. 51)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504374(US11040034, Ex. No. 53)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504375(US11040034, Ex. No. 54)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287679(US10085984, Example 57 | US11040034, Ex. No. 57)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287680(US10085984, Example 58 | US11040034, Ex. No. 58)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287681(US10085984, Example 59 | US11040034, Ex. No. 59)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287683(US10085984, Example 61 | US11040034, Ex. No. 61)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287684(US10085984, Example 62 | US11040034, Ex. No. 62)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287685(US10085984, Example 63 | US11040034, Ex. No. 63)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287686(US10085984, Example 64 | US11040034, Ex. No. 64)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287688(US10085984, Example 66 | US11040034, Ex. No. 66)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287689(US10085984, Example 67 | US11040034, Ex. No. 67)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287691(US10085984, Example 69 | US11040034, Ex. No. 69)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287692(US10085984, Example 70 | US11040034, Ex. No. 70)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287693(US10085984, Example 71 | US11040034, Ex. No. 71)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287694(US10085984, Example 72 | US11040034, Ex. No. 72)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287696(US10085984, Example 74 | US11040034, Ex. No. 74)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287697(US10085984, Example 75 | US11040034, Ex. No. 75)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287698(US10085984, Example 76 | US11040034, Ex. No. 76)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287703(US10085984, Example 81 | US11040034, Ex. No. 81)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287705(US10085984, Example 83 | US11040034, Ex. No. 83)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM504406(US11040034, Ex. No. 84)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287707(US10085984, Example 85 | US11040034, Ex. No. 85)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287708(US10085984, Example 86 | US11040034, Ex. No. 86)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287709(US10085984, Example 87 | US11040034, Ex. No. 87)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B1, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287709(US10085984, Example 87 | US11040034, Ex. No. 87)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287710(US10085984, Example 88 | US11040034, Ex. No. 88)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 11B2, mitochondrial(Homo sapiens (Human))
Phasebio Pharmaceuticals

US Patent
LigandPNGBDBM287711(US10085984, Example 89 | US11040034, Ex. No. 89)
Affinity DataIC50:  50nMAssay Description:Enzyme assays for inhibitor screening employed CYP11B2 and CYP11B1 enzyme enriched microsomes and were run at the Km of the respective substrates. Pr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 272 total ) | Next | Last >>
Jump to: